Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherBASIC SCIENCE INVESTIGATIONS

Evaluation of the Role of Hexokinase Type II in Cellular Proliferation and Apoptosis Using Human Hepatocellular Carcinoma Cell Lines

Keun Jae Ahn, Hee Sung Hwang, Jeon Han Park, Seong Hye Bang, Won Jun Kang, Mijin Yun and Jong Doo Lee
Journal of Nuclear Medicine September 2009, 50 (9) 1525-1532; DOI: https://doi.org/10.2967/jnumed.108.060780
Keun Jae Ahn
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hee Sung Hwang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeon Han Park
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Seong Hye Bang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Won Jun Kang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mijin Yun
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jong Doo Lee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Additional Files
  • FIGURE 1. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1. 

    Expression profile of HKII in established stable cells. Expression of HKII is significantly increased after transfection in both SNU449 human HCC cell line and control Chang cells. HepG2 cell line was used as positive control for HKII. β-actin was used as loading controls for Western blot analysis. SNU449-HKII = stable cells after transfection of HKII; Chang-HKII = stable cells after transfection of HKII.

  • FIGURE 2. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2. 

    Measurement of 18F-FDG uptake levels in established stable cells. 18F-FDG PET images after transfection of HKII show significantly increased 18F-FDG uptake in both SNU449 and Chang cells by approximately 52% and 40%, respectively.

  • FIGURE 3. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3. 

    Subcellular localization of HKII in SNU449 and SNU449-HKII cells. Confocal microscopy shows markedly increased HKII expression after transfection (SNU449-HKII), and large proportion of HKIIs are mitochondrially associated. (A–C) SNU449 cells. (D–F) SNU449 cells after transfection of HKII. HKII protein is shown in A and D (red); mitochondria are shown in B and E (green); and HKII colocalized with mitochondria is shown in C and F (yellow-orange).

  • FIGURE 4. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4. 

    Effects of overexpressed HKII on cell growth and anticancer treatment response. Cellular proliferation is significantly increased after HKII transfection, approximately 1.5- to 2-fold, compared with nontransfected cells (A). After treatment with cisplatin (10 μg/mL) for 3 d at 37°C, there was 2- and 8-fold increase in cell survival 2 and 3 d after treatment, respectively (B). All measurements were performed in triplicate; error bars indicate SEM. Comparisons were subjected to Student t test. A.U. = arbitrary unit. *P < 0.05. **P < 0.01.

  • FIGURE 5. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 5. 

    Effects of overexpressed HKII on AMPK phosphorylation. Activated form of AMPK (p-AMPK) is significantly decreased after HK II transfection (SNU449-HKII). Oligomycin (0.5 μM, 30 min) served as positive control of p-AMPK because it is AMPK activator.

  • FIGURE 6. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 6. 

    Effects of PI3K inhibitor treatment. Activated form of Akt (p-Akt) was significantly increased after HKII transfection (SNU449-HKII), compared with control cells without transfection (SNU449). After treatment with 50 μM PI3K inhibitor LY294002 for 1 h, p-Akt level significantly decreased. β-actin served as loading control.

  • FIGURE 7. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 7. 

    Translocation of HK II from mitochondria to cytoplasm after treatment with PI3K inhibitor. Total amount of HKII protein was not changed after treatment with 50 μM PI3K inhibitor LY294002 for 1 h (A). HKII is expressed more in mitochondrial fraction before treatment. After treatment with PI3K inhibitor, mitochondrial fraction decreased whereas cytosolic fraction increased (B). β-actin and Hsp 60 served as loading controls. Cyt = cytoplasmic fraction X; Mt = mitochondria.

Additional Files

  • Figures
  • Supplemental Data

    Files in this Data Supplement:

    • Supplemental Figures
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 50 (9)
Journal of Nuclear Medicine
Vol. 50, Issue 9
September 2009
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Evaluation of the Role of Hexokinase Type II in Cellular Proliferation and Apoptosis Using Human Hepatocellular Carcinoma Cell Lines
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Evaluation of the Role of Hexokinase Type II in Cellular Proliferation and Apoptosis Using Human Hepatocellular Carcinoma Cell Lines
Keun Jae Ahn, Hee Sung Hwang, Jeon Han Park, Seong Hye Bang, Won Jun Kang, Mijin Yun, Jong Doo Lee
Journal of Nuclear Medicine Sep 2009, 50 (9) 1525-1532; DOI: 10.2967/jnumed.108.060780

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Evaluation of the Role of Hexokinase Type II in Cellular Proliferation and Apoptosis Using Human Hepatocellular Carcinoma Cell Lines
Keun Jae Ahn, Hee Sung Hwang, Jeon Han Park, Seong Hye Bang, Won Jun Kang, Mijin Yun, Jong Doo Lee
Journal of Nuclear Medicine Sep 2009, 50 (9) 1525-1532; DOI: 10.2967/jnumed.108.060780
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • 18F-FDG PET/CT Can Predict Survival of Advanced Hepatocellular Carcinoma Patients: A Multicenter Retrospective Cohort Study
  • A Continuously Infused Microfluidic Radioassay System for the Characterization of Cellular Pharmacokinetics
  • PU.1 is linking the glycolytic enzyme HK3 in neutrophil differentiation and survival of APL cells
  • Combined RNA Interference of Hexokinase II and 131I-Sodium Iodide Symporter Gene Therapy for Anaplastic Thyroid Carcinoma
  • Google Scholar

More in this TOC Section

  • How Sensitive Is the Upper Gastrointestinal Tract to 90Y Radioembolization? A Histologic and Dosimetric Analysis in a Porcine Model
  • 11C-Methionine PET of Myocardial Inflammation in a Rat Model of Experimental Autoimmune Myocarditis
  • Counting Rate Characteristics and Image Distortion in Preclinical PET Imaging During Radiopharmaceutical Therapy
Show more Basic Science Investigations

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire